Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/101480

Prevalence and clonal distribution of pcpA, psrP and Pilus-1 among pediatric isolates of Streptococcus pneumoniae
Selva Jové, Laura; Ciruela, Pilar; Blanchette, Krystle; Amo Moran, Eva del; Pallarés Giner, Roman; Orihuela, Carlos J.; Muñoz-Almagro, Carmen
Universitat de Barcelona
Streptococcus pneumoniae is the leading cause of vaccine-preventable deaths globally. The objective of this study was to determine the distribution and clonal type variability of three potential vaccine antigens: Pneumococcal serine-rich repeat protein (PsrP), Pilus-1, and Pneumococcal choline binding protein A (PcpA) among pneumococcal isolates from children with invasive pneumococcal disease and healthy nasopharyngeal carriers. We studied by Real-Time PCR a total of 458 invasive pneumococcal isolates and 89 nasopharyngeal pneumococcal isolates among children (total = 547 strains) collected in Barcelona, Spain, from January 2004 to July 2010. pcpA, psrP and pilus-1 were detected in 92.8%, 51.7% and 14.4% of invasive isolates and in 92.1%, 48.3% and 18% of carrier isolates, respectively. Within individual serotypes the prevalence of psrP and pilus-1 was highly dependent on the clonal type. pcpA was highly prevalent in all strains with the exception of those belonging to serotype 3 (33.3% in serotype 3 isolates vs. 95.1% in other serotypes; P<.001). psrP was significantly more frequent in those serotypes that are less apt to be detected in carriage than in disease; 58.7% vs. 39.1% P<.001. Antibiotic resistance was associated with the presence of pilus-1 and showed a negative correlation with psrP. These results indicate that PcpA, and subsequently Psrp and Pilus-1 together might be good candidates to be used in a next-generation of multivalent pneumococcal protein vaccine.
-Pneumococs
-Infeccions per pneumococs
-Vacuna antipneumocòccica
-Vacunes
-Vacunació dels infants
-Resistència als medicaments
-Pediatria
-Streptococcus pneumonia
-Pneumococcal Infections
-Pneumococcal vaccine
-Vaccines
-Vaccination of children
-Drug resistance
-Pediatrics
cc-by (c) Selva Jové, Laura et al., 2012
http://creativecommons.org/licenses/by/3.0/es
Artículo
Artículo - Versión publicada
Public Library of Science (PLoS)
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Selva Jové, Laura; Ciruela, Pilar; Blanchette, Krystle; Amo Moran, Eva del; Pallarés Giner, Roman; Orihuela, Carlos J.; Muñoz-Almagro, Carmen
Amo Moran, Eva del; Esteva, Cristina; Hernández Bou, Susanna; Galles, Carmen; Navarro, Marian; Sauca, Goretti; Díaz Conradi, Álvaro; Gassiot, Paula; Marti, Carmina; Larrosa, Nieves; Ciruela, Pilar; Jane, Mireia; Sá-Leao, Raquel; Muñoz-Almagro, Carmen; García García, Juan José; Catalan Study Group of Invasive Pneumococcal Disease [autoria conjunta]
Selva Jové, Laura; Benmessaoud, Rachid; Lanaspa, Miguel; Jroundi, Imane; Moraleda, Cinta; Acácio, Sozinho; Iñigo, Melania; Bastiani, Alien; Monsonis, Manuel; Pallarés Giner, Roman; Bassat Orellana, Quique; Muñoz-Almagro, Carmen
Selva Jové, Laura; Benmessaoud, Rachid; Lanaspa, Miguel; Jroundi, Imane; Moraleda, Cinta; Acácio, Sozinho; Iñigo, Melania; Bastiani, Alien; Monsonis, Manuel; Pallarés Giner, Roman; Bassat Orellana, Quique; Muñoz-Almagro, Carmen
Ciruela, Pilar; Broner, Sonia Judith; Izquierdo, Conchita; Hernández, Sergi; Muñoz-Almagro, Carmen; Pallarés Giner, Roman; Jané, Mireia; Domínguez García, Àngela; Catalan Study Group of Invasive Pneumococcal Disease [autoria conjunta]